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Abstract 
A new system for continuous flow chemiluminescence detection, based on the use of a simple and low-
priced lens-free digital camera (with Complementary Metal Oxide Semiconductors technology) as 
detector, is proposed for the quantitative determination of paracetamol in commercial pharmaceutical 
formulations. Through the camera software, AVI video files of the chemiluminescence emission are 
captured and then, using friendly ImageJ public domain software (from National Institutes for Health), 
properly processed in order to extract the analytical information. The calibration graph was found to be 
linear over the range 0.01-0.10 mg L-1 and over the range 1.0-100.0 mg L-1 of paracetamol, being the limit 
of detection of 10 µg L-1. No significative interferences were found. Paracetamol was determined in three 
different pharmaceutical formulations: Termalgin®, Efferalgan® and Gelocatil®. The obtained results 
compared well with those declared on the formulation label and with those obtained through the official 
analytical method of British Pharmacopoeia. 
 














Chemiluminescence (CL) is usually defined as the production of electromagnetic radiation as a result of a 
chemical reaction. One of the reaction products is in an excited state and emits light on returning to its 
ground state. The process by which chemiluminescence is generated is the same as that for photolumi-
nescence (fluorescence and phosphorescence) except that the former requires no light excitation source. 
The analytical interest of CL lies in the ability to produce molecules that emit light without prior 
irradiation, which avoids problems arising from stray light, unselective excitation and instability of the 
light source. Moreover, the advantages of CL analysis include low limits of detection and a wide linear 
range. Analytical applications of liquid-phase chemiluminescence have increased considerably over the 
last three decades and, up to date, the analytical literature published a number of applications for the 
determination of both, inorganic and organic compounds in a variety of industrial, clinical, 
biotechnological and environmental matrices.  Chemiluminescence methods have been also frequently 
used in recent years for the analysis of pharmaceutical compounds [1-7]. 
Chemiluminescence is usually measured either in (a) static mode or (b) continuous-flow mode. In the 
first one, a syringe is employed to deliver portions of sample and chemiluminescent reagent(s), which are 
mixed in a cell housed in a luminometer chamber located in front of the detector window. From the 
obtained CL curve (variation of the chemiluminescence intensity with the reaction time), different 
parameters (height, area, profile width, decay rate) can be related to the analyte concentration. In the 
second mode, analyte and chemiluminescent reagent(s) are continuously flowing through different 
channels before merging (Fig. 1). Chemiluminescence intensity is then measured at a fixed position 
beyond the merging point, where a flow cell is placed in front of the detector window. The flow rates and 
the volume between the merging point and the flow cell position are the parameters which determine the 
reaction time and so the arising CL intensity [2]. 
Thus, the essential components of a flow chemiluminescence detection system are the reagent mixing 
chamber, the flow-cell, the photodetector (frequently a photomultiplier tube or PMT) and an electronic 
data acquisition and processing software. Many instruments designed for other purposes include all these 
components and can thus be used for chemiluminescence measurements. In fact and in order to measure 
CL emission intensity, it has been a common practice in analytical chemistry to use suitably modified 
ordinary instruments, such as a spectrofluorimeter, where the emission monochromator has been replaced 
with an appropriate device (a parabolic mirror) to reflect the whole emitted light by the CL reaction 
through the PMT. Moreover, CL measures can also be generally achieved with simple, robust and often 
home-made PMT based instrumentation [2, 6, 7]. 
Besides photomultiplier tubes, which are relatively expensive devices, other usually employed 
detection systems for CL are silicon photodiodes and in the last decades, the increasing technical 
improvement and affordability of digital image-based systems hardware and software, have promoted the 
use of charge-coupled devices (CCD) and complementary metal oxide semiconductors (CMOS) as 
suitable detectors in CL analytical methods as well as in other kinds of quantitative chemical analyses [8-
12]. 
Digital cameras capture images by means of CCD or more frequently CMOS sensors. Each cell (pixel 
or photosite) in a CCD or CMOS acts as a light-sensitive individual element providing an electrical 
response that can be digitized to build an optical image. A black and white (B&W) sensor consisting of 8-
bit pixels can respond to 28 = 256 levels of grey ranging from 0 (black) to 255 (white). This allows each 
pixel in a captured image to be assigned a numerical value from 0 to 255 (grey level or analytical signal) 
which can be subsequently used for analytical calibration. As a result, a digital image-based system can 
be used as a suitable analytical detector, since each captured image provides a vast amount of information 
[8-12]. 
Both technologies (CCD and CMOS) are intended for taking images digitally with several similarities 
and differences in the signal processing, performance and cost. Both are pixelated metal oxide 
semiconductors which convert light into electrical charge and then to electrical signals. The main 
difference is that each pixel of a CCD transfers charge as an analog signal to be converted to voltage 
outside the pixel, so it needs an external analog-to-digital converter, while a CMOS has its own charge-
to-voltage conversion system integrated within each pixel, being its output a digital signal. There has been 
debate among pros and cons of the two systems and until recent years CCD has been more widely 
adapted for use as detectors, perhaps owing to its earlier and more mature development. Nevertheless, 
although theoretically CCD images are superior, CMOS works faster and can be produced at cheaper rate. 
In fact, owing to its advantages over CCD, CMOS are being nowadays massively employed as detectors 
in all kind of digital image-based systems [9, 10]. 
There is an extensive market offer of such technology at very affordable prices and different types of 
commercial CCD or CMOS digital image-based systems such as digital cameras, mobile phone cameras, 
desktop scanners or even webcams have been described for use as an alternative detector unit for 
chemical or biochemical analysis systems, especially when analysis are based on colour changes [10]. 
The digital image-based detectors can replace the more expensive UV-VIS, fluorescence and 
chemiluminescence spectrophotometers. For instance, a webcam is a very common low cost CMOS based 
device broadly used in computer/internet applications and its application for immunoassay microplate 
reading or fluorescence detection has been yet reported, though so far the use of a webcam as an 
analytical detector is still infrequent [13, 14]. 
The analytical applications of the liquid-phase chemiluminescence have been [2] classified into (a) 
direct methods, those where the light emission arouses from the analyte oxidation and (b) indirect 
methods, those where the analyte usually playing a different role in the CL emission (e.g. reagent, 
catalyst, quencher, enhancer) and which involve well known chemiluminescence emitters, being luminol, 
acridinium salts, oxalate esters, dioxetanes and tris(2,2´-bipyridyl)ruthenium(II) the most usually 
employed reagents in this kind of analytical applications [1-7]. 
In liquid phase (aqueous solutions), luminol (5-amino-2,3-dihydrophthalazine-1,4-dione) is the most 
usually employed CL reagent [15]. Luminol reacts in alkaline solution with a strong oxidizing agent such 
as hydrogen peroxide, hexacyanoferrate (III), permanganate, N-bromosuccinimide or periodate in the 
presence of a catalyst (usually a metal or metal-containing compound or an enzyme). The redox reaction 
yields 3-aminophthalate in an excited electronic state, which returns to the ground state with the emission 
of visible light (CL) around 425nm. Luminol-based systems [1-7, 15] have been broadly exploited in the 
quantitative analysis of numerous compounds (including pharmaceuticals), because of its relatively high 
quantum efficiency (quantum yield) and susceptibility of its CL mechanism to a vast number of 
compounds. In fact, in luminol-based procedures, the analyte itself usually plays either as inhibitor or 
enhancer of the CL emission, making possible to correlate the analyte concentration vs the intensity of CL 
emission (analytical signal). 
Here we propose the development of new system of continuous-flow CL detection, for the 
quantitative determination of paracetamol in pharmaceutical formulations, based on the use of a simple 
and low-priced CMOS lens-free digital black and white camera.  
As far as the authors know, this is the first attempt to employ a lens-free imaging (CMOS) camera to 
monitor a chemiluminescent signal in a flow system by recording video to obtain the analytical signal and 







All reagents used were analytically pure. K3[Fe(CN)6], H2O2 (30% w/v; 100 vol.), NaOH, NH4Cl, NH3, 
Na2HPO4, Na2CO3, borax, ascorbic acid, citric acid anhydrous, sodium benzoate, sorbitol, sulphuric acid, 
hydrochloric acid, ammonium cerium sulphate and ferroin from Panreac (Castellar del Vallés, Barcelona, 
Spain). Acetylsalicylic acid, caffeine, hydroxypropyl methylcellulose, magnesium stearate, 
methocarbamol, microcrystalline cellulose, polyvinylpyrrolidone, saccharin, silicon dioxide, stearic acid, 
talc and wheat starch from Guinama (La Pobla de Vallbona, Valencia, Spain). Starch from Merck 
(Darmstadt, Germany). Codeine phosphate from Uquifa (Barcelona, Spain). Luminol from Fluka 
(nowadays Sigma-Aldrich: St. Louis, Missouri, USA). 
Solutions were prepared from water purified by reverse osmosis, de-ionized to 18 MΩ⋅cm with a 
Sybron/Barnstead Nanopure II water purification system furnished with a fibre filter of 0.2 μm pore size.  
The signal (AVI file) was taken with a Luna-QHY 5 lens-free digital B&W camera (equipped with a 
monochrome CMOS MT9M001 from Micron: Manassas, Virginia, USA), usually intended for 
astronomical purposes, from Lunático Astronomía: Torrelodones, Madrid, Spain 
(http://tienda.lunatico.es/). An integration time of 1000 ms and a gain of 50 were employed. The obtained 
CL signal was processed with the public domain software ImageJ (v 1.43g), Windows version, developed 
by the National Institutes for Health and available for free download at http://rsbweb.nih.gov/ij.  
The finally proposed flow manifold (Fig. 2) consisted of a peristaltic pump (Gilson Minipuls 2; 
Middleton, WI, USA) which pumped paracetamol (Flow-rate 1,  1.2 mL min-1 of paracetamol aqueous 
solution), hexacyanoferrate(III) (Flow-rate 2, 1.2 mL min-1 of 1.4 x 10-3 mol L-1 K3[Fe(CN)6] aqueous 
solution), hydrogen peroxide (Flow-rate 3, 2.0 mL min-1 of 1.0 x 10-2 mol L-1 H2O2 aqueous solution) and 
luminol (Flow-rate 4, 4.3 mL min-1 of 1.0 x 10-3 mol L-1 luminol and 0.1 mol L-1 NaOH solution) through 
PTFE tubes (0.8 mm internal diameter). Finally, all channels merged in a T shaped piece positioned 2 cm 
before entering the flow cell, which consists on a flat spiral-coiled quartz tube (1.0 mm internal diameter, 
3 cm total diameter of the flow cell, without gaps between loops).  The flow cell was backed by a mirror 
for maximum light collection and placed 2 mm from the CMOS.  The T-piece, flow cell and camera were 
placed in a home-made, absolutely light-tight box.  The output was fed to a computer equipped with the 




Each session work, a video file of the generated chemiluminescence was recorded through the CCD 
software and saved as a VideoFile.avi. 
All the obtained video files were processed with the software ImageJ. The processing sequence (4 
steps) was as follows (operation A>B>C means select command B on menu A and then select 
subcommand C in command B): 
1: File>Open>VideoFile.avi 
2: Edit>Selection>Select All 
3: Plugins>Stacks-T-functions>Intensity v Time Monitor>List 
4: File>Save as>Plot Values.xls 
The generated data (Plot Values.xls file) was finally imported into Microsoft Excel for statistical 
analysis. Bearing on mid the 8 bits nature of the CMOS, the signal was always comprised and so 
expressed between 0 (total inhibition) and 255 (maximum CL emission: no inhibition) arbitrary units 
(a.u.). 
The results were compared with those obtained through the official methods of British Pharmacopoeia 
[17]. The official procedure is based on the drug solution in sulphuric acid (1 mol L-1) followed by boiling 
(reflux) for 1 hour and a final titration (in HCl, 2 mol L-1) with ammonium cerium sulphate with ferroin 
as indicator. 
 
Results and discussion 
 
The main goal of the experimental work was the development of new system of continuous-flow CL 
detection, for the quantitative determination of paracetamol in pharmaceutical formulations, based on the 
use of a simple and low-priced CMOS lens-free digital black and white camera (initially intended to 
obtain telescopic astronomical images), which has the advantage of being even more robust and simpler 
than a webcam because it do not have optical systems in front of CMOS sensor, allowing to easily place 
the spiral CL flow cell in front of the detector. Through the camera software, a number of images per 
second are captured when the reagents reach the flow cell and the CL emission is produced and then, the 
obtained AVI video file is properly processed in order to extract the analytical information by using 
ImageJ, public domain software, designed and freely distributed by NIH, which yields the intensities 
(mean grey level) of each image (frame) in the captured video sequence. The data generated by means of 
ImageJ are then imported into Microsoft Excel (Microsoft, Redmond, WA) becoming the register of the 
CL analytical signal. 
The presented procedure is based on procedure published by one of the authors [16], where the 
chemiluminescence arising from the well-known chemiluminescent system luminol-H2O2-Fe(CN)63-, is 
employed. The method is based on the oxidation of paracetamol by hexacyanoferrate (III) and their 
subsequent inhibitory effect on the reaction between luminol and hydrogen peroxide (produced by de 
consumption of the hexacyanoferrate (III)), which allows relating the CL intensity (analytical signal) with 
the paracetamol (analyte) concentration. 
Bearing in mind that CL signal intensity is time-depending, all the work was performed, instead of in 
a batch mode, by means of a continuous flow manifold, where the time of measurement after mixing of 
solutions is accurately controlled by the flow rates.  
Instrumental parameters (Luna-QHY 5 CMOS based camera) were initially maintained in its native 
value, namely: Integration time, 1000 ms and Gain, 50. 
All experiments were conducted in the four-channel configuration of Fig. 2. This was the simplest 
continuous flow manifold that allowed individual solutions of the three reagents and the analyte to be 
used. Also, it ensured that the chemiluminescent reaction started after the last T-junction. In order to 
establish the conditions required to obtain nearly but not completely saturated chemiluminescence 
(maximum empirical intensity near but below 255 a.u. to be able to use a wide enough inhibition range on 
the y-axis), the study and optimization of chemical and continuous flow variables was performed by using 
a univariate method. 
 
Optimization of flow, chemical and CMOS parameters 
 
First and pumping deionized water by channel 1, we studied the effect of the concentrations of the three 
reagents (luminol, hexacyanoferrate (III) and hydrogen peroxide). Bearing in mind the former work [16], 
the concentrations were studied in the next intervals: luminol, 1.0 x 10-4 – 1.0 x 10-2 mol L-1 (in NaOH 
0.05 M); hexacyanoferrate (III), 1.0 x 10-3 – 1.0 x 10-1 mol L-1 and hydrogen peroxide, 1.0 x 10-4 – 1.0 x 
10-2 mol L-1. The concentrations adopted were: 1.0 x 10-3 mol L-1 luminol (in NaOH 0.05 M); 1.0 x 10-2 
mol L-1 of hydrogen peroxide (see Fig. 3a) and, in order to obtain nearly but not completely saturated 
chemiluminescence, 1.4 x 10-3 mol L-1 hexacyanoferrate (III) (see Fig. 3b).  
The influence of the pH and the nature of alkaline media employed to dissolve luminol was then 
studied between pH 8.91 and 12.35 by using NH4Cl/NH3 (pH from 8.91 to 10.05), Borax/NaOH (pH from 
9.52 to 11.20), Na2HPO4/NaOH (pH from 11.25 to 11.72) and NaOH (pH 12.35), being NaOH the 
medium which yield the maximum signal and thus selected for further work (Fig. 4). 
The NaOH concentration was then optimized by studying values comprised over the range 0.05 – 0.25 
mol L-1 (measured pH between 11.51 and 12.71, respectively). The highest useful analytical signal 
(higher concentrations saturated the detector response with analytical signal over 255 a.u.) was obtained 
at pH 12.50 (NaOH 0.1 mol L-1), which was chosen for subsequent experiments. 
Then flow rates were optimized by studying values of the variables over the range 1 – 4.5 mL min-1. 
Attending to the maximum analytical signal, the chosen conditions were Q1 = Q2 = 1.2 mL min-1; Q3 = 2.0 
mL min-1; Q4 = 4.3 mL min-1 which yield a signal of 251 a.u. 
Next, the influence of paracetamol concentration over the CL signal (inhibition) was tested at 
concentrations ranging from 0.01 to 100 mg L-1. The first one showed an inhibition of 4 a.u. whereas 100 
mg L-1 showed an inhibition of 235 a.u. 
The influence of the reactor lengths on the paracetamol oxidation rate (See Fig. 2, L1 and L2) were 
then studied over the range = 10 – 150 cm. Testing different paracetamol concentrations ranging from 
0.01 to 100 mg L-1, no differences were observed, showing that at the previously established flow rates, 
the reactor lengths have no influence over the reaction rate. So, initial values of L1= L2 = 50 cm were 
maintained. 
Once continuous flow variables were optimized, chemical variables were re-optimized. Significant 
differences were not observed so chemical variables were maintained in the previously optimized values. 
Finally, the influence of instrumental parameters was also studied. Different values of the integration 
time and gain of the CMOS camera were tested in the ranges 0 – 5000 ms and 0 – 100, respectively. 
Obviously, to obtain the same value of CL signal, high gain values needed shorter integration times; 
however, the signal had higher noise, being 3% the RSD of the blank signal. On the other hand, longer 
integration times needed lower gain, and the noise was lower (RSD of the blank signal, 0.1%); 
nevertheless, at lower gain values, low concentrations of paracetamol (below 0.1 mg L-1) were not 
detected. Consequently, an integration time of 1000 ms and a gain of 55 were finally selected as the best 
compromise between signal noise (RSD of the blank signal, 0.3%) and a lower limit of detection. 
  
Analytical figures of merit. 
 
Limit of Detection 
 
Considering the inhibition of the CL emission (Ih, in arbitrary units, a.u.) as the analytical signal, the limit 
of detection was empirically determined by testing diluted solutions of paracetamol until 10 µg L-1, which 
was experimentally confirmed as the concentration yielding a signal (2.8 a.u.) higher than the 
corresponding to the blank (0.0 a.u.) more three times the standard deviation of the blank (0.8 a.u.). The 





The calibration graph was found to be linear over the range 0.01 – 0.10 mg L-1 and over the range 1.0 – 
100.0 mg L-1 of paracetamol concentration (Fig. 5). For the first range, the regression equation was Log 
(Ih) = 1.82 + 0.690 Log(C) (where C is the paracetamol concentration in mg L-1) and the correlation 
coefficient (N=5) was 0.9999. For the second range, the regression equation was Log (Ih) = 1.70 + 0.270 
Log(C) (where C is the paracetamol concentration in mg L-1) and the correlation coefficient (N=5) was 
0.9995.  Double logarithmic scale was employed in order to obtain a linear relation between Ih and C. 
The obtained correlation coefficients (both higher than 0.999) show a good linear behaviour in both 




The between day reproducibility study was performed working each day (5 days) with freshly prepared 
solutions, being the paracetamol concentrations (five values for each range) comprised in the range 0.01 – 
0.10 mg L-1 and the range 1.0 – 100.0 mg L-1. For the first range, the mean (N=5) slope obtained was 
0.686, with an RSD of 4.1% and mean correlation coefficient of 0.9970 (RSD of 0.8%). For the second 
range, the mean (N=5) slope obtained was 0.282, with an RSD of 2.2% and mean correlation coefficient 




The influence of foreign compounds and excipients that may be found in pharmaceutical formulations 
containing paracetamol was also studied. Synthetic solutions containing 1.0 mg L-1 of the analyte and 
different amounts of foreign substances (up to 100 mg L-1 or saturated solution) were measured. The 
relative errors (%) were calculated by comparing the analytical signal with that obtained by testing a 
solution of pure paracetamol at the same concentration (1.0 mg L-1).  The obtained results are depicted in 
Table 1.  The obtained data shows no significant influence of the studied foreign compounds; therefore, 
the proposed method shows a relevant selectivity and can be used for the determination of paracetamol in 
samples containing those compounds, without previous separation steps. 
 
Assay of real samples 
 
Paracetamol was determined in three different pharmaceutical formulations:  
 
Termalgin® (tablets, from NOVARTIS): paracetamol 500 mg. 
Efferalgan® (tablets, from BRYSTOL-MYERS SQUIBB): paracetamol 500 mg. 
Gelocatil® (tablets, from GELOS): paracetamol 650 mg. 
 
The results (average of three determinations) were compared with those declared on the formulation 
label and with those obtained through the official methods of British Pharmacopoeia [17]. The official 
procedure is based on the drug titration with ammonium cerium sulphate with ferroin as indicator. Table 2 
shows the obtained results (average recovery ± 95 % CI and % RSD); it is possible to affirm that the 
proposed method provides good results, perfectly comparable with those declared by the manufacturers 
and with those obtained with the official method (the proposed method yields even better results than the 




A low-priced device like CMOS lens-free digital B&W camera, specifically intended for astronomical 
imaging purpose, shows to be useful to detect and to measure CL emission intensity. The proposed 
camera has the advantage of being more robust and simpler than other kind of digital devices, because it 
do not have optical systems in front of CMOS sensor, allowing to easily place the spiral CL flow cell in 
front of the detector. The fundamental handicap could be the relatively low sensitivity of the CMOS 
sensor (versus PMTs or cooled CCDs), which only could be used to measure CL arising from high 
quantum yield systems. Nevertheless, bearing in mind the vast number of applications of such systems [1-
7, 15] there are a lot of potential uses of CMOS sensors in chemiluminescence detection. 
Moreover, in this case, the performance of the new proposed method compares very well with the 
previous one [16] bearing on mind that there, the calibration graph inhibition-concentration was found to 
be linear over the range 2.5-12.5 mgL-1 of paracetamol (correlation coefficient of 0.997, N=6) and the 
limit of detection was 2.1 mgL-1 of analyte. 
Through the camera software, AVI video files of the CL emission are captured and then, using 
friendly ImageJ public domain software (by NIH), properly processed in order to extract the analytical 
information. The data generated by means of ImageJ are then imported into Microsoft Excel (Microsoft, 
Redmond, WA) becoming the register of the CL analytical signal. 
In addition to competitive accuracy, precision and sensitivity, the new proposed procedure shows a 
relevant selectivity which allows analysing the proposed samples without separation steps of the 
chromatography-based methods. The obtained results for the tested pharmaceuticals, compares well with 
those declared by the manufacturer and with the obtained by the official (BP) method and it could be 
emphasized than the proposed method yields better results than the official one, especially for the 
Gelocatil formulation.  On the other hand, the new procedure, opposite to the titrimetric official 
procedure, has all the advantages arising from continuous flow methodology and could be easily exported 
to other continuous flow analytical methodologies like FIA, SIA or HPLC.  
Finally, it could be emphasized that the proposed method can be especially advantageous for scenarios 
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Fig. 1 Position of observation window relative to emission-time curve for flow-through 
chemiluminescence measurements. Hatched region under the curve represents the 






Fig. 2 Proposed continuous flow assembly for paracetamol determination. (See text). 
1, paracetamol (1.2 mL min-1 of paracetamol aqueous solution); 2, hexacyanoferrate 
(III) (1.2 mL min-1 of 1.4 x 10-3 mol L-1 K3[Fe(CN)6] aqueous solution); 3, hydrogen 
peroxide (2.0 mL min-1 of 1.0 x 10-2 mol L-1 H2O2 aqueous solution); 4, luminol (4.3 
mL min-1 of 1.0 x 10-3 mol L-1 luminol and 0.1 mol L-1 NaOH solution); 5, peristaltic 
pump; 6, light-tight box  containing the spiral flow cell and the CMOS camera; 7, 































Fig. 3a  Influence of luminol and hydrogen peroxide concentrations. Luminol: Series1, 
0.0001 mol L-1; Series2, 0.0005 mol L-1; Series3, 0.001 mol L-1; Series4, 0.005 mol L-1; 
Series5, 0.01 mol L-1. Hydrogen peroxide concentrations: 0.1 mol L-1, 0.01 mol L-1 and 
0.001 mol L-1. Hexacyanoferrate (III) concentration was maintained at 0.001 mol L-1 in 
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Fig. 3b Influence of hexacyanoferrate(III) concentration. Luminol 0.001 mol L-1; 





















































Fig. 5 Calibration graphs over the range (a) 0.01 – 0.10 mg L-1  
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Table 1 Influence of foreign compounds. All solutions containing 1.0 mg L-1 of paracetamol. 
Foreign compound C / mg L-1  Er / % 
Acetylsalicylic acid 100 0.0 
Ascorbic acid 5.0 -3.5 
Caffeine 100 -1.3 
Citric acid anhydrous 100 0.1 
Codeine Phosphate 100 0.0 
Hydroxypropyl methylcellulose Saturated solution 0.0 
Magnesium stearate Saturated solution 0.0 
Methocarbamol 100 -0.6 
Microcrystalline cellulose Saturated solution 0.0 
Polyvinylpyrrolidone 100 -0.2 
Saccharin 100 1.5 
Silicon dioxide Saturated solution 0.0 
Sodium benzoate 100 0.4 
Sodium carbonate 100 0.0 
Sorbitol 100 0.3 
Starch Saturated solution 0.0 
Stearic acid Saturated solution 0.1 
Talc Saturated solution 0.0 








Table 2 Tested pharmaceutical formulations. 
*Average recovery (of three determinations) ± 95 % CI and precision (% RSD). 
Pharmaceutical  
Formulation 
Label claim  
per tablet / mg 
Official BP method found 
 amount* per tablet / mg 
 
Proposed method found 
 amount* per tablet / mg 
 
Termalgin® 500 504 ± 5 (95 % CI) (0.4 % RSD) 500 ± 5 (95 % CI) (0.4 % RSD) 
Efferalgan® 500 510 ± 5 (95 % CI) (0.4 % RSD) 503 ± 5 (95 % CI) (0.4 % RSD) 
Gelocatil® 650 679 ± 7 (95 % CI) (0.4 % RSD) 658 ± 7 (95 % CI) (0.4 % RSD) 
 
 
 
